Abstract
Due to the chemical complexity of the human organism it is difficult to imagine that any one chemical agent would produce a single pharmacological effect. The “magic bullet” theory, envisioned by Paul Erlich around the turn of the century, postulated that after drug administration the drug is absorbed, transported by the blood to its site of action, performs the desired pharmacological action without effecting other cells or organs and then excreted. It was soon discovered that such selective chemicals were nonexistent. After searching for decades, scientists had to be satisfied by finding chemicals with the minimal number and least severe side effects. Interestingly, naltrexone seems to be close to the description of the “magic bullet.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blumberg H, Pachter IJ and Matossian Z: US Patent 3, 332, 950 (July 25, 1976)
Cone EJ: Human metabolite of naltrexone (N-cyclopropylmethylnoroxymorphone) with a novel C-6 isomorphine configuration. Tetrahedron Lett 23:2607–2610, 1973
Hiller J and Simon E: New York University Medical School, Personal Communication, 1979
Martin WR, Gorodetzky CW and McClane TK: An experimental study in the treatment of narcotic addicts with cyclazocine. Clin Pharmacol Ther 7:455–465, 1966
Verebey K and Mulé SJ: Naltrexone pharmacology, pharmacokinetics and metabolism: Current status. Am J Drug Alcohol Abuse 2:357–363, 1975
Verebey K and Mulé SJ: Naltrexone and 6β-naltrexol plasma levels in schizophrenic patients after large doses of naltrexone. Res Commun Psychol, Psychiatry & Behavior 4:311–317, 1979
Verebey K, Chedekel MA, Mulé SJ and Rosenthal D: Isolation and identification of a new metabolite of naltrexone in human blood and urine. Res Commun Chem Pathol Pharmacol 12:67–84, 1975
Verebey K, DePace A, Jukofsky D, Volavka JV and Mulé SJ: Quantitative determination of 2-hydroxy-3-methoxy-6β-naltrexol (HMN), naltrexone, and 6β-naltrexol in human plasma, red blood cells, sauva and urine by gas liquid chromatography. J Analytical Toxicol 4:33–37, 1980
Verebey K, Volavka J, Mulé SJ and Resnick RB: Naltrexone: Disposition, metabolism and effects after acute and chronic dosing. Clin Pharmacol Ther 20:315–328, 1976
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Spectrum Publications, Inc.
About this chapter
Cite this chapter
Verebey, K. (1984). Clinical Pharmacology and Therapeutic Use of the Narcotic Antagonist: Naltrexone. In: Serban, G. (eds) Social and Medical Aspects of Drug Abuse. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6320-0_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-6320-0_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6322-4
Online ISBN: 978-94-011-6320-0
eBook Packages: Springer Book Archive